Home Cart 0 Sign in  

[ CAS No. 36923-17-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 36923-17-8
Chemical Structure| 36923-17-8
Structure of 36923-17-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 36923-17-8 ]

Related Doc. of [ 36923-17-8 ]

Alternatived Products of [ 36923-17-8 ]

Product Details of [ 36923-17-8 ]

CAS No. :36923-17-8 MDL No. :MFCD08063340
Formula : C7H8N2O3S Boiling Point : -
Linear Structure Formula :- InChI Key :RJFPBECTFIUTHB-INEUFUBQSA-N
M.W : 200.21 Pubchem ID :11735790
Synonyms :

Calculated chemistry of [ 36923-17-8 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.43
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 50.14
TPSA : 108.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.55
Log Po/w (XLOGP3) : -3.11
Log Po/w (WLOGP) : -1.18
Log Po/w (MLOGP) : -0.35
Log Po/w (SILICOS-IT) : -1.07
Consensus Log Po/w : -1.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.94
Solubility : 1760.0 mg/ml ; 8.79 mol/l
Class : Highly soluble
Log S (Ali) : 1.39
Solubility : 4900.0 mg/ml ; 24.5 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : 0.81
Solubility : 1300.0 mg/ml ; 6.52 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.81

Safety of [ 36923-17-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 36923-17-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 36923-17-8 ]
  • Downstream synthetic route of [ 36923-17-8 ]

[ 36923-17-8 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 108260-00-0 ]
  • [ 36923-17-8 ]
Reference: [1] Patent: CN102558198, 2016, B,
[2] Patent: CN102558198, 2016, B,
[3] Patent: CN102558198, 2016, B,
  • 2
  • [ 91868-79-0 ]
  • [ 36923-17-8 ]
  • [ 64485-93-4 ]
YieldReaction ConditionsOperation in experiment
2.59 g
Stage #1: With dmap; dicyclohexyl-carbodiimide In ethanol at 20℃; for 0.5 h;
Stage #2: With 1-hydroxy-pyrrolidine-2,5-dione In ethanol at 20℃; for 0.5 h;
The cefotaxime sodium was prepared according to the preparation method described in Chinese Patent CN 102807573 A.2.05 g of 2- (2-amino-4-thiazolyl) -2-methoxyiminoacetic acid was dissolved in 20 ml of ethanol,Adding 1.85 g of 4-dimethylaminopyridine and 3.05 g of dicyclohexylcarbodiimide, and the mixture was stirred at room temperature for 30 min,Adding 1.20 g of N-hydroxysuccinimide and stirring at room temperature for 30 min,40 ml of saturated ammonium chloride solution was added, and the mixture was extracted with 40 ml of ethyl acetate. The ethyl acetate layer was separated,The organic phase was washed with saturated brine,Dried over anhydrous sodium sulfate, the solvent was evaporated, and the column chromatography (ethyl acetate / methanol = 10: 1)The active ester was 2.75 g. 2.75 g of the active ester was dissolved in 20 ml of dichloromethane,Join7-amino-none-3-Cephalosporin ring-4-carboxylic acid1.92 g and triethylamine (10 ml). After stirring for 8 h at room temperature,The pH was adjusted to 4.5 with 1 mol / L hydrochloric acid solution and reacted at -5 ° C for 2 h. Dichloromethane extraction, activated carbon decolorization, drying and then concentrated 3.04g cefotaxime. 3.04 g of ceftizole was dissolved in 10 ml of ethyl acetate,A 20 ml of ethyl acetate in which 5 g of sodium bicarbonate was dissolved was added dropwise,25 stirring crystallization, 30 under reduced pressure drying white powder 2.59g.
Reference: [1] Patent: CN106279208, 2017, A, . Location in patent: Paragraph 0051; 0052; 0053
Same Skeleton Products
Historical Records